Detalles de la búsqueda
1.
Multidisciplinary team meetings in Hematology: a national mixed-methods study.
BMC Cancer
; 23(1): 950, 2023 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805458
2.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438802
3.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611196
4.
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.
Blood
; 124(2): 204-10, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24869941
5.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689746
6.
Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home.
Support Care Cancer
; 24(12): 5007-5014, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27525991
7.
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Cancer
; 121(14): 2393-9, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25845577
8.
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas.
Br J Cancer
; 113(6): 934-44, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26284337
9.
Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012.
Br J Haematol
; 170(2): 218-22, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824587
10.
Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
; 20(12): 1905-11, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25072780
11.
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.
Blood
; 120(22): 4317-23, 2012 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23002117
12.
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.
Transfusion
; 54(2): 389-97, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23711330
13.
Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies.
BMC Palliat Care
; 13: 57, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25859160
14.
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Lancet
; 379(9825): 1508-16, 2012 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22482940
15.
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.
Blood
; 117(6): 1834-9, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21123825
16.
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Haematologica
; 103(11): e519-e521, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29794147
17.
Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.
Am J Hematol
; 88(9): 747-53, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23733486
18.
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
Br J Haematol
; 158(2): 232-237, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571447
19.
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Crit Care Med
; 40(1): 104-11, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21926591
20.
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Blood
; 116(12): 2040-5, 2010 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20548096